Phase 1 Stent Clinical Trials
8 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction
Refractory Acute Myeloid LeukemiaBlasts More Than 5 Percent of Bone Marrow Nucleated CellsPersistent Disease
Ohio State University Comprehensive Cancer Center28 enrolled2 locationsNCT04049539
Recruiting
Phase 1Phase 2
Pilot Study of the α Prototype NIMBLE System: Feasibility, Safety, and Initial Performance in Non-Invasive Detection of Coronary In-Stent Restenosis
In-stent RestenosisStent FractureStent Complication
Nimble Diagnostics S.L.30 enrolled1 locationNCT06968858
Recruiting
Phase 1Phase 2
Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease
Post Operative PainUrolithiasisStent Complication+1 more
University of Texas Southwestern Medical Center80 enrolled1 locationNCT06158620
Recruiting
Phase 1Phase 2
Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn
Persistent Pulmonary Hypertension of Newborn
Sohag University40 enrolled1 locationNCT04898114
Withdrawn
Phase 1
Comparative assessment of the absorption of a generic formulation of 4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol hydrogen tartrate oral liquid against the innovator 4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol hydrogen tartrate oral liquid conducted under fasting conditions in healthy male and female volunteers.
4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol hydrogen tartrate oral liquid is used to provide temporary relief for persistent unproductive and dry coughs
Zenith Technology Corporation Limited30 enrolled1 locationACTRN12621001252808
Withdrawn
Phase 1
Evaluation of the Safety and Efficacy of CMB-012 in Subjects with Chemical Burns of the Cornea and/or Persistent Corneal Epithelial Defects (PCED)
Chemical BurnPersistent Corneal Epithelial Defect
Combangio, Inc.6 enrolled1 locationACTRN12619001724167
Completed
Phase 1
A Phase I randomized blinded single dose comparison of the safety pharmacokinetics and pharmacodynamics of SYN008 and omalizumab (Xolair) in healthy adult subjects
Moderate to severe persistent asthmaChronic idiopathic urticaria
Clinical Network Services (CNS) Pty Ltd80 enrolled1 locationACTRN12616000145404
Terminated
Phase 1
Combination Gefitinib and Methotrexate for the Treatment of Persistent Gestational Trophoblastic Disease: A Phase I Clinical Trial
Persistent Gestational Trophoblastic Disease
Miss Orla McNally, Director Gynaecological Oncology & Dysplasia12 enrolled1 locationACTRN12611000104954